RedShift BioAnalytics: Funding, Investors & Team (Aug 2026)
RedShiftBio provides an infrared technology with advanced data analytics to facilitate better, faster decision making in biopharmaceutical development from discovery to market via the direct measurement of previously undetectable change in protein structural attributes critical to drug product efficacy and quality. It has developed a Microfluidic Modulation Spectroscopy (MMS) platform in response to a customer’s request for a better solution, and rather than repurpose outdated tools and methods designed originally for other applications. They started a new and developed MMS from the ground up specifically with the protein scientist in mind. The company was founded in 2005 and is headquartered in Burlington, Massachusetts.
RedShift BioAnalytics has raised $20.0M across 1 funding round on record, the most recent a Series E of $20.0M announced in Oct 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
RedShift BioAnalytics Company Profile and Key Stats
Latest funding round on record: Oct 2021.
RedShift BioAnalytics Funding Rounds
RedShift BioAnalytics Founders and Leadership Team
No contact details are on record for this team yet.
RedShift BioAnalytics Funding Compared to Other Biotechnology Startups
RedShift BioAnalytics' latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like RedShift BioAnalytics in Biotechnology and Burlington
Companies Similar to RedShift BioAnalytics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
RedShift BioAnalytics Funding FAQs
What does RedShift BioAnalytics do?
RedShiftBio provides an infrared technology with advanced data analytics to facilitate better, faster decision making in biopharmaceutical development from discovery to market via the direct measurement of previously undetectable change in protein structural attributes critical to drug product efficacy and quality. It has developed a Microfluidic Modulation Spectroscopy (MMS) platform in response to a customer’s request for a better solution, and rather than repurpose outdated tools and methods designed originally for other applications. They started a new and developed MMS from the ground up specifically with the protein scientist in mind. The company was founded in 2005 and is headquartered in Burlington, Massachusetts.
How much funding has RedShift BioAnalytics raised?
RedShift BioAnalytics has raised $20.0M across 1 round on record. The most recent is a Series E of $20.0M announced in Oct 2021.
When did RedShift BioAnalytics last raise funding?
RedShift BioAnalytics' most recent funding round on record is a Series E of $20.0M, announced in Oct 2021.
Who is the CEO of RedShift BioAnalytics?
Julien Bradley is listed as CEO at RedShift BioAnalytics.
Where is RedShift BioAnalytics headquartered?
RedShift BioAnalytics is based in Burlington, Massachusetts, United States.
How many employees does RedShift BioAnalytics have?
RedShift BioAnalytics is in the 11-50 employee band.
How does RedShift BioAnalytics' funding compare to other Biotechnology startups?
RedShift BioAnalytics' latest round of $20.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's RedShift BioAnalytics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for RedShift BioAnalytics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.